DrugPatentWatch Database Preview
Cetuximab - Biologic Drug Details
Summary for cetuximab
| Tradenames: | 1 |
| Patents: | 515 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for cetuximab |
Pharmacology for cetuximab
| Mechanism of Action | HER1 Antagonists |
US Patents for cetuximab
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Imclone | ERBITUX | cetuximab | VIAL; INTRAVENOUS | 125084 | 001 | 2004-06-18 | ➤ Try a Free Trial | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (Seoul, KR) | ➤ Try a Free Trial | RX | Orphan | search |
| Imclone | ERBITUX | cetuximab | VIAL; INTRAVENOUS | 125084 | 001 | 2004-06-18 | ➤ Try a Free Trial | Yeda Research and Development Co. Ltd. (Rehovot, IL) | ➤ Try a Free Trial | RX | Orphan | search |
| Imclone | ERBITUX | cetuximab | VIAL; INTRAVENOUS | 125084 | 001 | 2004-06-18 | ➤ Try a Free Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | ➤ Try a Free Trial | RX | Orphan | search |
| Imclone | ERBITUX | cetuximab | VIAL; INTRAVENOUS | 125084 | 001 | 2004-06-18 | ➤ Try a Free Trial | OP NANO CO., LTD. (Taipei, TW) TRENDMED CO., LTD. (Beitou Dist., Taipei, TW) | ➤ Try a Free Trial | RX | Orphan | search |
| Imclone | ERBITUX | cetuximab | VIAL; INTRAVENOUS | 125084 | 001 | 2004-06-18 | ➤ Try a Free Trial | VentiRx Pharmaceuticals, Inc. (Seattle, WA) | ➤ Try a Free Trial | RX | Orphan | search |
| Imclone | ERBITUX | cetuximab | VIAL; INTRAVENOUS | 125084 | 001 | 2004-06-18 | ➤ Try a Free Trial | Wake Forest University Health Sciences (Winston-Salem, NC) | ➤ Try a Free Trial | RX | Orphan | search |
| Imclone | ERBITUX | cetuximab | VIAL; INTRAVENOUS | 125084 | 001 | 2004-06-18 | ➤ Try a Free Trial | University of Georgia Research Foundation, Inc. (Athens, GA) | ➤ Try a Free Trial | RX | Orphan | search |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for cetuximab
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2563936 | ➤ Try a Free Trial |
| Australia | 2012332021 | ➤ Try a Free Trial |
| China | 1886118 | ➤ Try a Free Trial |
| Singapore | 172983 | ➤ Try a Free Trial |
| Croatia | P20150307 | ➤ Try a Free Trial |
| Brazil | PI0620888 | ➤ Try a Free Trial |
| Israel | 175773 | ➤ Try a Free Trial |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for cetuximab
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2015000013 | Germany | ➤ Try a Free Trial | PRODUCT NAME: POMALIDOMID UND SEINE PHARMAZEUTISCH AKZEPTABLEN SALZE, SOLVATE, HYDRATE ODER STEREOISOMERE (IMNOVID); REGISTRATION NO/DATE: EU/1/13/850 20130805 |
| 448 | Luxembourg | ➤ Try a Free Trial | 91448, EXPIRES: 20140915 |
| 2015 00006 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: POMALIDOMID OG FARMACEUTISK ACCEPTABLE SALTE, SOLVATER, HYDRATER ELLER STEREOISOMERER HERAF; REG. NO/DATE: EU/1/13/850 20130805 |
| 0150005 00140 | Estonia | ➤ Try a Free Trial | PRODUCT NAME: POMALIDOMIID;REG NO/DATE: EU/1/13/850 08.08.2013 |
| 0753 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: TRASTUZUMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826 |
| 138 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: RITUXIMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20140326 |
| 449 | Luxembourg | ➤ Try a Free Trial | 91449, EXPIRES: 20140915 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
